Dermatology
Lynk doses first cohort in Phase Ib trial of psoriasis therapy
Lynk Pharmaceuticals has dosed the first cohort of patients in a Phase Ib clinical trial of LNK01004 ointment to treat…
Quoin completes dosing half patients in study of QRX003 topical lotion
Quoin Pharmaceuticals has completed dosing half of the patients in an open-label study of QRX003 topical lotion to treat Netherton…
TrialSpark doses first patient in Phase II trial of AD therapy
TrialSpark has dosed the first patient in a Phase II clinical trial of ASN008-201 gel for the treatment of pruritus…
Kymera reports positive results from Phase I trial of IRAK4 degrader
Kymera Therapeutics has reported positive results from a Phase I clinical trial of its lead programme, KT-474 (SAR444656), for the…
University of Southampton trial shows spironolactone’s potential for acne
A group of researchers led by the University of Southampton, UK, conducted a trial that showed the potential of spironolactone…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
HiST Pharma receives FDA IND clearance for psoriasis vulgaris drug trial
HiST Pharma subsidiary Psoriasis Research Institute of Guangzhou (PRIG) has secured approval for its investigational new drug (IND), TC Cream,…
Numab doses first subject in antibody therapeutic trial for AD
Numab Therapeutics has dosed the first subject in a Phase I clinical trial of NM26-2198, a bi-specific antibody to treat…
Sareum receives approval to commence SDC-1801 trial in Australia
Sareum Holdings has received approval for its application submitted for initiation of a Phase I clinical trial of SDC-1801 in…
Incyte reports Phase II SCRATCH-AD study results of AD therapy
Incyte has announced results from its Phase II SCRATCH-AD trial assessing the short-term clinical benefits of Opzelura (ruxolitinib) cream 1.5%…
Eli Lilly unveils new data from atopic dermatitis therapy trials
Eli Lilly and Company has reported new secondary data from the Phase III trials investigating lebrikizumab for the treatment of…